of Dec-21 stood at Bt87,828mn, decreasing from Bt99,600mn at ending Dec-20. Net debt to EBITDA (excluding lease liabilities and license payable) was 0.8x. Total equity reported Bt81,825mn, increasing
% from lower long-term borrowing. Net debt to EBITDA (excluding lease liabilities and license payable) remained healthy at 0.8x. Total equity was at Bt85,816mn, which increased 4.9% from higher retained
% of the 1H/2017 consolidated net income, which will be paid from the unappropriated retained earnings that derived from tax exemption profit portion according to Board of Investment (BOI) privilege
assets of the Company and its 2 subsidiaries amounts to 5.38 percent of the total assets of the Company and its subsidiaries, according to the consolidated financial statements of the Company, which were
amended Upon calculation of the maximum transaction size is equal to 2. 38 percent based on the net tangible asset ( NTA) criteria ( calculated by using the information shown in the company's consolidated
9/11 Summary of financial statement of Medical Vision Company Limited as of 31 December 2019 Item Value (Baht) Total Assets 25,390,781.70 Total Liabilities 22,670,829.42 Total Shareholders' Equity
The opinions of the Independent Financial Advisor on the connected transaction (For the purpose of translation only) 0 The opinions of the Independent Financial Advisor on the connected transaction by Thai Wacoal Public Company Limited Presented to Shareholders of Thai Wacoal Public Company Limited Prepared by 8 March 2019 This English report of the Independent Financial Advisor’s Opinions has been prepared solely for the convenience of foreign shareholders of Thai Wacoal Public Company Limited...
Disposition of Assets, 2004 (collectively, the “Notifications on Acquisition or Disposal”) The maximum transaction value calculated based on consolidated financial statements for the period ending 31 December
14 March 2019. Consequently, the company has consolidated GLOW’s operating results for 18 days after the acquisition into the consolidated financial statements of the company. For the preparation of